Plasmodium falciparum causes more than 600,000 malaria deaths annually. Whether the monoclonal antibody L9LS can protect children from P. falciparum infection in a region where the organism is endemic is unclear.
Research findings are summarized in a new Quick Take video.
To see the full article, follow this link: [ Ссылка ]
#pediatrics #infectiousdisease #clinicaltrials #nejm
![](https://i.ytimg.com/vi/7a_oY_TfCn0/maxresdefault.jpg)